Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.666, 2012-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 652, 2012-01 ,pp. :
Access to resources
Recommend
Sunitinib gets the gist in imatinib-resistance
Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. :
Adjuvant imatinib worth the cost in GIST patients
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 617, 2010-01 ,pp. :
Imatinib for priority review by US FDA for GIST recurrence.
Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. :
By Lyseng-Williamson K. Jarvis B.
Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. :